LIPFENDRA
Active substance: enlicitide decanoate
TABLET, FILM COATED · ENLICITIDE DECANOATE 20 mg/1
United StatesActive
Marketing holder: Merck Sharp & Dohme LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- ENLICITIDE DECANOATE · 20 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208f-a520-7a40-beb5-9a490e3b636a;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0006-5084
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 0006-5084 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0006-5084 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0006-5084 · Verified 2026-10-09 · open in source